Day: 30 January 2024

Early Access Programs (EAPs) are a crucial aspect of the pharmaceutical landscape, providing a pathway for patients with serious or life-threatening conditions to access investigational drugs prior to official approval. For pharmaceutical companies, understanding and effectively managing EAPs can be a game-changer. This blog post will delve into what EAPs entail and how pharmaceutical companies…